Several studies have demonstrated that down-regulation of the FOXA subfamily members, FOXA1 and FOXA3, play an important role in the pathogenesis and progression of NAFLD in both humans and experimental animals [29–31]. The gene discussed is FOXA1; the disease is metabolic dysfunction-associated steatotic liver disease.